Sutro Biopharma Inc buy Wedbush
Start price
03.04.24
/
50%
€4.78
Target price
03.04.25
€7.38
Performance (%)
-23.01%
Price
31.07.24
€3.68
Summary
This prediction is currently active. The price of Sutro Biopharma Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.01%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | 5.587% | 5.587% |
iShares Core DAX® | 0.786% | 1.251% |
iShares Nasdaq 100 | 1.855% | -2.687% |
iShares Nikkei 225® | 3.947% | 2.199% |
iShares S&P 500 | 1.787% | 0.151% |
Comments by Wedbush for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Wedbush for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.84
14.05.24
14.05.24
€7.40
14.05.25
14.05.25
-4.17%
31.07.24
31.07.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.58
26.03.24
26.03.24
€7.38
26.03.25
26.03.25
-19.65%
31.07.24
31.07.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.08
14.11.23
14.11.23
€11.07
14.11.24
14.11.24
76.92%
31.07.24
31.07.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.72
23.10.23
23.10.23
€11.29
23.10.24
23.10.24
35.29%
31.07.24
31.07.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.86
11.08.23
11.08.23
€10.95
11.08.24
11.08.24
-4.66%
31.07.24
31.07.24